These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33961025)

  • 21. Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-label, longterm extension studies.
    Wollenhaupt J; Silverfield J; Lee EB; Curtis JR; Wood SP; Soma K; Nduaka CI; Benda B; Gruben D; Nakamura H; Komuro Y; Zwillich SH; Wang L; Riese RJ
    J Rheumatol; 2014 May; 41(5):837-52. PubMed ID: 24692527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A patient with anti-NXP2-positive dermatomyositis and syphilis.
    Nguyen M; Hai J; Bovenberg MSS; Wilken R; Kiuru M; Brassard A; Tartar D
    Dermatol Online J; 2020 Feb; 26(2):. PubMed ID: 32239891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies.
    Fleischmann R; Kremer J; Tanaka Y; Gruben D; Kanik K; Koncz T; Krishnaswami S; Wallenstein G; Wilkinson B; Zwillich SH; Keystone E
    Int J Rheum Dis; 2016 Dec; 19(12):1216-1225. PubMed ID: 27451980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tofacitinib for the Treatment of Pyoderma Gangrenosum.
    Kochar B; Herfarth N; Mamie C; Navarini AA; Scharl M; Herfarth HH
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):991-993. PubMed ID: 30404036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tofacitinib versus methotrexate in rheumatoid arthritis.
    Lee EB; Fleischmann R; Hall S; Wilkinson B; Bradley JD; Gruben D; Koncz T; Krishnaswami S; Wallenstein GV; Zang C; Zwillich SH; van Vollenhoven RF;
    N Engl J Med; 2014 Jun; 370(25):2377-86. PubMed ID: 24941177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme.
    Curtis JR; Lee EB; Kaplan IV; Kwok K; Geier J; Benda B; Soma K; Wang L; Riese R
    Ann Rheum Dis; 2016 May; 75(5):831-41. PubMed ID: 25902789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case Series on Patients on Tofacitinib in Combination With a Biologic.
    Barroso NS; Miller EZ; Furst DE
    J Clin Rheumatol; 2018 Sep; 24(6):349-351. PubMed ID: 29280829
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffuse Soft-Tissue Swelling in Antinuclear Matrix Protein-2 Antibody-Associated Dermatomyositis Sine Dermatitis.
    Chompoopong P; Liewluck T; McMenomy BP; Harper CM
    Mayo Clin Proc; 2021 Oct; 96(10):2517-2518. PubMed ID: 34425965
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy.
    Ambler GR; Chaitow J; Rogers M; McDonald DW; Ouvrier RA
    J Rheumatol; 2005 Sep; 32(9):1837-9. PubMed ID: 16142885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.
    Clowse ME; Feldman SR; Isaacs JD; Kimball AB; Strand V; Warren RB; Xibillé D; Chen Y; Frazier D; Geier J; Proulx J; Marren A
    Drug Saf; 2016 Aug; 39(8):755-62. PubMed ID: 27282428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of anti-NXP2 antibody-positive dermatomyositis with improvement of clinical symptoms and disappearance of autoantibody after resection of uterine cancer.
    Fushida N; Kobayashi T; Oishi K; Maeda S; Matsushita T; Mizumoto Y; Takehara K; Hamaguchi Y
    Eur J Dermatol; 2020 Oct; 30(5):612-613. PubMed ID: 32972905
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
    Fleischmann R; Mysler E; Hall S; Kivitz AJ; Moots RJ; Luo Z; DeMasi R; Soma K; Zhang R; Takiya L; Tatulych S; Mojcik C; Krishnaswami S; Menon S; Smolen JS;
    Lancet; 2017 Jul; 390(10093):457-468. PubMed ID: 28629665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen.
    Chen YY; Lin SY; Chen YC; Yang CC; Lan CE
    Eur J Dermatol; 2019 Dec; 29(6):667-669. PubMed ID: 31903968
    [No Abstract]   [Full Text] [Related]  

  • 34. A striking treatment option for recalcitrant calcinosis in juvenile dermatomyositis: tofacitinib citrate.
    Sözeri B; Demir F
    Rheumatology (Oxford); 2020 Dec; 59(12):e140-e141. PubMed ID: 32754736
    [No Abstract]   [Full Text] [Related]  

  • 35. Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria.
    Smolen JS; Aletaha D; Gruben D; Zwillich SH; Krishnaswami S; Mebus C
    Arthritis Rheumatol; 2017 Apr; 69(4):728-734. PubMed ID: 27907269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid arthritis: can tofacitinib be used as first-line monotherapy for RA?
    Onuora S
    Nat Rev Rheumatol; 2014 Aug; 10(8):443. PubMed ID: 25003770
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
    Charles-Schoeman C; van der Heijde D; Burmester GR; Nash P; Zerbini CAF; Connell CA; Fan H; Kwok K; Bananis E; Fleischmann R
    J Rheumatol; 2018 Feb; 45(2):177-187. PubMed ID: 29142036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients.
    Best M; Jachiet M; Molinari N; Manna F; Girard C; Pallure V; Cosnes A; Lipsker D; Hubiche T; Schmutz JL; Le Corre Y; Cordel N; Dandurand M; Dereure O; Guillot B; Du-Thanh A; Bulai Livideanu C; Chasset F; Bouaziz JD; Francès C; Bengoufa D; Vincent T; Bessis D;
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1164-1172. PubMed ID: 29237090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tofacitinib as a treatment of alopecia areata in adolescents.
    Morales-Miranda AY; Bueno-Arias GM; Aguirre-Félix ÓG; Tovar-Franco R
    Bol Med Hosp Infant Mex; 2019; 76(4):182-187. PubMed ID: 31303654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemphigus foliaceus associated with anti-NXP2 autoantibody-positive dermatomyositis.
    Fujimoto N; Takayama S; Hamaguchi Y; Fujimoto M; Tanaka T
    Acta Derm Venereol; 2014 Jul; 94(4):478-9. PubMed ID: 24217940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.